The ongoing pandemic has led to chaos in many industries, including in clinical trial design. The use of RWE (real world evidence) might be one solution for upended trials and incomplete data. A recent article details these challenges and how RWE can be used to make important decisions in the context of clinical trials.
“The article summarizes new and innovative uses of RWE to tackle challenges associated with sample size, historical data (or lack thereof), endpoint selection, and other features of advanced clinical trial design. The pandemic has refined both the technological resources and human resources to deploy studies more reliant on RWE.” Read more here.
(Source: Radek Wasiak (Cytel), Sreeram Ramagopalan (Roche), Cytel, 1/22/21)